SynthesisEuropean journal of clinical pharmacology2021

The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis.

Shanshan Xie et al.PubMed ↗Publisher ↗

No numbers read from the abstract.